作者: Leslee J. Shaw , Daniel S. Berman
DOI: 10.1016/J.AMJCARD.2005.06.024
关键词:
摘要: The utility of stress myocardial perfusion imaging (MPI) for the diagnosis and prognosis coronary artery disease (CAD) has been firmly established in numerous clinical studies become an essential component practice. Stress MPI is now used regularly to guide initial risk stratification management patients with CAD. Because provides assessment physiologic significance CAD, it a particularly attractive procedure assessing follow-up risk. Today, sequential being increasingly track progression, assess risk, detect restenosis following revascularization, evaluate efficacy aggressive medical therapy risk-factor modification. By providing serial snapshots its impact on perfusion, may alter treatment decisions ultimately improve long-term patient outcomes. Use changes surgical or therapies tested currently Clinical Outcomes Using Revascularization Aggressive Drug Evaluation (COURAGE) Adenosine Sestamibi Single-Photon Emission Computed Tomography Postinfarction (INSPIRE) trials.